30 F.4th 777
8th Cir.2022Background
- Centene acquired Health Net after a 2015 board-approved merger; a joint proxy statement solicited shareholder approval in September 2015.
- Plaintiffs (Centene shareholders) allege directors concealed Health Net’s serious financial problems (poorly designed/unprofitable policies, disputed substance-abuse claim liabilities, potential tax exposure) before and after the proxy.
- After closing, Centene’s April 2016 10-Q omitted setting premium deficiency reserves (PDRs) despite the audit committee’s April 25 decision that PDRs should be at least $117 million; by July 2016 Centene disclosed $390 million in additional reserves causing a >8% stock drop.
- Several directors and officers sold Centene stock between shareholder approval and the adverse July disclosure.
- Plaintiffs filed a consolidated derivative complaint without making a pre-suit demand, alleging: §14(a) proxy violations, fiduciary-duty breaches (care, loyalty, good faith, candor), securities-related disclosure breaches, insider trading (against two directors), and unjust enrichment.
- The district court dismissed with prejudice for failure to plead demand futility with particularity; the Eighth Circuit affirmed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether demand was excused under Delaware law (Tri‑State test) | A majority of directors knew of and concealed Health Net problems, so demand would be futile | Plaintiffs failed to plead particularized facts showing a majority of directors face a substantial likelihood of liability | Demand futility not established; plaintiffs did not plead particularized facts showing at least half the board faced substantial likelihood of liability |
| §14(a) / Proxy misleadingness and materiality | Proxy omitted material facts about Health Net and made misleading pro forma projections causing shareholder injury | Proxy contained bold cautionary language and no actionable materially false statements; plaintiffs failed PSLRA particularity and scienter pleading | Dismissed as to §14(a): plaintiffs did not plead a material misrepresentation/omission with required particularity or scienter for outside directors |
| Breach of fiduciary duty (care vs loyalty / bad faith) | Directors failed in due diligence, allowed overpayment, and acted in bad faith by concealing problems | Centene’s charter exculpates duty-of-care claims; plaintiffs plead only knowledge, not conscious bad faith or intent to harm required for loyalty breaches | Duty-of-care claims cannot support liability due to Delaware §102(b)(7); loyalty/bad-faith claims fail for lack of particularized facts showing subjective bad faith |
| Insider trading (two directors) — sufficiency for demand futility | Insider trading by Neidorff and Gephardt indicates wrongdoing and taints board impartiality | Only two directors are accused; that is insufficient to show a majority would face substantial likelihood of liability or be conflicted | Insider-trading claim against two directors alone does not excuse demand because it does not show a majority of directors face substantial likelihood of liability |
| Duty-of-disclosure claims based on April 10-Q vs. Proxy | Plaintiffs treat April 10-Q and Proxy as disclosure breaches tied to fiduciary duties and securities violations | Duty of disclosure (in the merger context) applies to the Proxy; SEC filings like 10-Q implicate general duties but plaintiffs failed to plead particularized facts of material omission/liability | Claims based on the April 10-Q and Proxy disclosures dismissed for failure to plead material omissions and that at least half the board faced substantial likelihood of liability |
| Unjust enrichment as duplicative relief | Directors were unjustly enriched by compensation and stock sales tied to breaches | Unjust enrichment duplicates fiduciary breach and insider-trading claims and fails if those claims fail | Dismissed as duplicative; unjust enrichment cannot survive where underlying fiduciary and insider-trading claims fail |
Key Cases Cited
- United Food & Com. Workers Union & Participating Food Indus. Emps. Tri‑State Pension Fund v. Zuckerberg, 262 A.3d 1034 (Del. 2021) (articulates the three-part, director-by-director demand-futility test)
- Aronson v. Lewis, 473 A.2d 805 (Del. 1984) (traditional Delaware test for demand futility when board decision is challenged)
- Rales v. Blasband, 634 A.2d 927 (Del. 1993) (demand-futility test when the challenged decision was not made by the demand board)
- TSC Indus., Inc. v. Northway, Inc., 426 U.S. 438 (1976) (materiality standard for disclosure claims)
- Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (2011) (materiality: "total mix" analysis for securities disclosures)
- Malone v. Brincat, 722 A.2d 5 (Del. 1998) (fiduciary duty of disclosure and standards when soliciting shareholder action)
- McElrath v. Kalanick, 224 A.3d 982 (Del. 2020) (defines subjective bad faith and the high pleading bar for loyalty/bad‑faith claims)
- In re Caremark Int’l Inc. Derivative Litig., 698 A.2d 959 (Del. Ch. 1996) (oversight/monitoring claims and difficulty of stating Caremark claim)
- Gomes v. American Century Cos., 710 F.3d 811 (8th Cir. 2013) (standards for pleading and Rule 23.1 particularity in derivative suits)